Detection and molecular monitoring of FIP1L1-PDGFRA-positive diseases by analysis of patient-specific genomic DNA fusion junctions

/ Score, J. ; Walz, C. ; Jovanovic, J.V. .. — 2009-02

Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms

/ Ernst, Thomas ; Chase, Andrew ; Zoi, Katerina .. — 2010-09

Novel imatinib-sensitive PDGFRA activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like disease

/ Elling, Christian ; Erben, Phillipp ; Walz, Christoph .. — 2011-03-10

EZH2 mutational status predicts poor survival in myelofibrosis

/ Guglielmelli, P. ; Biamonte, F. ; Score, J. .. — 2011-11-10

Health economics in the field of osteoarthritis: an expert's consensus paper from the European society for clinical and economic aspects of osteopo...

/ Hiligsmann, M. ; Cooper, C. ; Arden, N. .. — 2013-12

The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients

/ Guglielmelli, Paola ; Lasho, Terra L. ; Rotunno, Giada .. — 2014-09

Republished: Value of biomarkers in osteoarthritis: current status and perspectives

/ Lotz, M. ; Martel-Pelletier, J. ; Christiansen, C. .. — 2014-03

Identification and functional characterization of imatinib-sensitiveDTD1-PDGFRB and CCDC88C-PDGFRB fusion genes in eosinophilia-associated myeloid/...

/ Gosenca, Darko ; Kellert, Beate ; Metzgeroth, Georgia .. — 2014-05

High prevalence but limited evidence in complementary and alternative medicine: guidelines for future research

/ Fischer, F. ; Lewith, G. ; Witt, C. .. — 2014

Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes

/ Schwaab, Juliana ; Knut, Marcin ; Haferlach, Claudia .. — 2014-09-27